$47.94
Value $1.6B
AEHR and AVGO stock compared: price, dividend, valuation and results, from SEC filings.
$47.94
Value $1.6B
$346.65
Value $1.64T
Aehr Test Systems (AEHR) has a market value of $1.6B and Broadcom (AVGO) $1.64T. Over the last year, with dividends, AEHR moved +142.9% and AVGO +2.6%. Dividend yield: AEHR none, AVGO 0.75%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
AEHR$1.6B
AVGO$1.64T
AVGO is 1,051 times AEHR
Revenue, 12 months
AEHR$50M
AVGO$89.1B
AVGO is 1,782 times AEHR
Net income, 12 months
AEHR-$7.1M
AVGO$38.3B
Operating margin
AEHR-28.3%
AVGO48.1%
76.4 points apart
ROIC
AEHR-5.1%
AVGO27.3%
32.4 points apart
P/E
AEHR–
AVGO43.0
Dividend yield
AEHR0.0%
AVGO0.8%
0.8 points apart
5-year return
AEHR+144.5%
AVGO+558.8%
414.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
AEHR+144.5%
AVGO+558.8%
| Period | AEHRWith dividends | AVGOWith dividends |
|---|---|---|
| 1 year since November 18, 2025 | +142.9%Price +142.9% | +2.6%Price +1.8% |
| 3 years since November 17, 2023 | +90.1%+23.9% a yearPrice +90.1% | +266.2%+54.1% a yearPrice +254.6% |
| 5 years since November 18, 2021 | +144.5%+19.6% a yearPrice +144.5% | +558.8%+45.8% a yearPrice +503.1% |
| 10 years since November 21, 2016 | +1,508.7%+32.0% a yearPrice +1,508.7% | +2,516.5%+38.6% a yearPrice +1,908.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
AEHRAehr Test SystemsAVGOBroadcom
| Price | $47.94 | $346.65 |
|---|---|---|
| Market value | $1.6B | $1.64T |
| Enterprise value (EV) | $1.5B | $1.68T |
| P/E | – | 43.0 |
| P/E, 5-year median | 24.7 | 30.4 |
| P/B | 7.0 | 16.5 |
| EV/EBIT | – | 39.2 |
| Free cash flow yield | – | 2.4% |
| Revenue, 12 months | $50M | $89.1B |
|---|---|---|
| Net income, 12 months | -$7.1M | $38.3B |
| Free cash flow, 12 months | -$5.4M | $39.4B |
| Earnings per share, 12 months | -$0.23 | $7.84 |
| Revenue growth, year on year | -15.2% | 23.9% |
| Revenue growth a year, past | +24.7%over 5 years | +21.7%over 5 years |
| EPS growth a year, past | – | +49.8%over 5 years |
| Gross margin | 35.3% | 68.8% |
|---|---|---|
| Operating margin | -28.3% | 48.1% |
| Net margin | -14.2% | 42.9% |
| ROIC | -5.1% | 27.3% |
| ROE | -3.3% | 45.4% |
| Cash | $105M | $24.0B |
|---|---|---|
| Total debt | $9.8M | $59.4B |
| Net debt / EBITDA | – | 0.8 |
| Interest cover | – | 13.7× |
| Dividend yield | – | 0.8% |
|---|---|---|
| Dividend per share, 12 months | – | $2.60 |
| Dividend growth a year, past | – | +12.7%over 5 years |
| Buyback yield | – | 0.2% |
| Shareholder yield | – | 0.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Broadcom ($1.64T) is about 1,051.0 times Aehr Test Systems ($1.6B), at today's prices.
Since November 21, 2016, AEHR's price moved +1,508.7% and AVGO's +1,908.4%. With dividends: AEHR +1,508.7% (+32.0% a year), AVGO +2,516.5% (+38.6% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Aehr Test Systems and 0.75% for Broadcom. Over the last twelve months they paid – and $2.60 per share.
Over the last twelve months, the net margin was -14.2% for Aehr Test Systems and 42.9% for Broadcom, and the operating margin -28.3% and 48.1%. Revenue was $50M and $89.1B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.